Interview: Massimo Visentin – Country Leader, Pfizer Italy
Massimo Visentin, Country Leader for Pfizer Italy, discusses the company’s remarkable success in 2015, his hopes…
Pfizer Italy
Last updated: 14.07.2021
Pfizer is one of the world’s premier innovative biopharmaceutical businesses: discovering, developing and delivering over 100 assorted medicines, vaccines and consumer healthcare products round the world. The company first commenced operations in Italy back in the 1950s, contributing significantly to the host nation’s economic and workforce development and investing heavily in innovation and R&D. Today Pfizer ranks as the largest pharmaceutical enterprise in the country.
Contact:
Address:
Sede Legale: Via Isonzo, 71 – 04100 Latina
Sede Commerciale: Via Valbondione 113, 00188 Roma
Tel: +39 06 331821
Fax: +39 06 33626019
Interviews
Interview with Cees Heiman, Country Manager, Pfizer Italy
Having led a 26 years long career in Pfizer, you have been involved in a number of different countries including…
Related
Italy / Market Access Reform: A Watershed Moment?
In recent months, a profound transformation has been occurring right at the core of the Italian pharmaceutical…
Italy / Mandatory COVID-19 Vaccines for Healthcare Workers; Chiesi & Angelini’s AI Investments; Sputnik V Manufacturing
The latest Italy Pharma News, including the government’s decision to make COVID-19 vaccines mandatory for all…
Italy / Stevanato’s $5 bn valuation; Zolgensma Approval; Sputnik V Manufacturing
The latest from Italian pharma, including the foreign minister’s plea for delivering on COVID-19 vaccine…
Italy / Menarini CEO on Averting Future Health Crises; Alfasigma Hackathon; January COVID Vaccines
A roundup of some of the most important recent stories from Italian pharma, including an in-depth interview with…
Pricing / Italy Takes Global Transparency Lead by Forcing Pharma to Disclose Public R&D Funding
In July 2020, Italy became the first country in the world to mandate pharma companies to disclose data surrounding…
News Roundup / Italy Pharma July 2020
Below we present recent news from Italy’s biopharma industry, including the recent acquisition of Stemline…
M&A / Menarini Makes Big US Oncology Move with Stemline Acquisition
Menarini Group, the largest Italian pharmaceutical company by turnover, has made its first move into the US…
Internationalization / Chiesi Moves into Rare Diseases & the US Market
Italian mid-cap firm Chiesi is continuing its expansion in the USA market with the launch of a Boston-based…
Interview: Luca G. Guidotti – Deputy Scientific Director, San Raffaele…
Prof. Luca G. Guidotti discusses the esteemed positioning of San Raffaele within the global scientific community,…
Interview: Gianvito Martino – Scientific Director & Director of the…
The division of neuroscience at the San Raffaele Scientific Institute is one of the best worldwide performers in…
Interview: Angelo Corti – Director, Division of Experimental Oncology, San…
Professor Angelo Corti, Director of the Experimental Oncology division of the SRSI, discusses approaches to…
Interview: Paola Pozzi – Head, Office of Biotechnology Transfer, San…
Dr. Paola Pozzi, the head of the Office of Biotechnology Transfer at the San Raffaele Scientific Institute,…
